C

China National Medicines Corp Ltd
SSE:600511

Watchlist Manager
China National Medicines Corp Ltd
SSE:600511
Watchlist
Price: 34.38 CNY -0.12% Market Closed
Market Cap: 25.9B CNY
Have any thoughts about
China National Medicines Corp Ltd?
Write Note

China National Medicines Corp Ltd
Operating Expenses

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

China National Medicines Corp Ltd
Operating Expenses Peer Comparison

Comparables:
1099
601607
600998
000963
Q
301015

Competitive Operating Expenses Analysis
Latest Figures & CAGR of Competitors

Company Operating Expenses CAGR 3Y CAGR 5Y CAGR 10Y
C
China National Medicines Corp Ltd
SSE:600511
Operating Expenses
-ÂĄ1.3B
CAGR 3-Years
2%
CAGR 5-Years
0%
CAGR 10-Years
-13%
Sinopharm Group Co Ltd
HKEX:1099
Operating Expenses
-ÂĄ26.4B
CAGR 3-Years
-4%
CAGR 5-Years
-8%
CAGR 10-Years
-13%
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
Operating Expenses
-ÂĄ21.2B
CAGR 3-Years
-3%
CAGR 5-Years
-3%
CAGR 10-Years
-11%
Jointown Pharmaceutical Group Co Ltd
SSE:600998
Operating Expenses
-ÂĄ7.1B
CAGR 3-Years
-5%
CAGR 5-Years
-8%
CAGR 10-Years
-16%
Huadong Medicine Co Ltd
SZSE:000963
Operating Expenses
-ÂĄ9.4B
CAGR 3-Years
-8%
CAGR 5-Years
-6%
CAGR 10-Years
-14%
Q
Qingdao Baheal Medical Inc
SZSE:301015
Operating Expenses
-ÂĄ1.4B
CAGR 3-Years
-9%
CAGR 5-Years
-10%
CAGR 10-Years
N/A

See Also

What is China National Medicines Corp Ltd's Operating Expenses?
Operating Expenses
-1.3B CNY

Based on the financial report for Jun 30, 2024, China National Medicines Corp Ltd's Operating Expenses amounts to -1.3B CNY.

What is China National Medicines Corp Ltd's Operating Expenses growth rate?
Operating Expenses CAGR 10Y
-13%

Over the last year, the Operating Expenses growth was 9%. The average annual Operating Expenses growth rates for China National Medicines Corp Ltd have been 2% over the past three years , and -13% over the past ten years .

Back to Top